Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
01:11:17 min
CLEAR ALL
Profound experiences of non-dual consciousness sometimes lead to lasting, and lastingly beneficial, changes in values and behavior.
1
Natalie Ginsberg, MAPS Policy and Advocacy Manager will interview Rick Doblin, Ph.D.
Psychedelic drugs: a dangerous and illegal scourge; a harmless way to “turn on, tune in, drop out” – or a valuable treatment for mental illness? Research is showing that substances like MDMA and magic mushrooms, long banished to society’s fringes, are proving effective in treating...
Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
2
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
Robert Jesse will offer a view, spanning the decade from the birth of Horizons to the present day, of the significant developments that have occurred in several areas of our field. Surely they amount to a re-emergence of psychedelics. People speak of a renaissance.
Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.
A small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results.